跳至主要内容
临床试验/NCT04498676
NCT04498676已完成不适用

50 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)

CAGE Bio Inc.2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
CAGE Bio Inc.
入组人数
50
试验地点
2
主要终点
Erythema

研究概览

简要总结

Consumer products or raw materials designed for consistent reapplication to areas of the skin may, under proper conditions, prove to be contact sensitizers or irritants in certain individuals. It is the intention of a Repeat Insult Patch Test (RIPT) to provide a basis for evaluation of this irritation/sensitization potential if such exists.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
21 Years 至 67 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals who are not currently under a doctor's care
  • Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the Investigator.
  • Individuals free of any acute or chronic disease that might interfere with or increase the risk of study participation.
  • Individuals who will complete a preliminary medical history form mandated by AMA Laboratories, Inc. and are in general good health.
  • Individuals, who will read, understand and sign an informed consent document relating to the specific type of study they are subscribing. Consent forms are kept on file and are available for examination on the premises of AMA Laboratories, Inc. only.
  • Individuals able to cooperate with the Investigator and research staff, willing to have test materials applied according to the protocol, and complete the full course of the study.

排除标准

  • Individuals under 18 years of age.
  • Individuals who are currently under a doctor's care.
  • Individuals who are currently taking any medication (topical or systemic) that may mask or interfere with the test results.
  • Subjects with a history of any acute or chronic disease that might interfere with or increase the risk associated with study participation.
  • Individuals diagnosed with chronic skin allergies.
  • Female volunteers who indicate that they are pregnant or lactating.

结局指标

主要结局

Erythema

时间窗: 21 days

Erythema rated on a numeric scale from 0 - 4. (0: None; 1: Minimal; 2: Mild; 3: Marked and 4: Severe erythema)

Sensitisation

时间窗: 48 hours

After a 10-14 day rest period, a challenge test was given at a different skin site to look for signals of a sensitization response measured by rating erythema on a scale from 0 - 4

次要结局

未报告次要终点

研究者

发起方
CAGE Bio Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

50 Human Subject Repeat Insult Patch Test | 临床试验